Senvest Management, LLC T2 Biosystems, Inc. Transaction History

Senvest Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$0.58 - $3.01 $514,157 - $2.67 Million	-886,478 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$1.47 - $3.16 $2.46 Million - $5.28 Million	-1,670,959 Reduced 65.34%	886,478 $1.49 Million
Q1 2019 May 14, 2019	SELL	$2.56 - $4.48 $702,812 - $1.23 Million	-274,536 Reduced 9.69%	2,557,437 $6.73 Million
Q4 2018 Feb 14, 2019	BUY	$2.98 - $6.86 $184,885 - $425,608	62,042 Added 2.24%	2,831,973 $8.52 Million
Q3 2018 Nov 13, 2018	BUY	$5.36 - $7.83 $567,088 - $828,414	105,800 Added 3.97%	2,769,931 $20.6 Million
Q2 2018 Aug 13, 2018	SELL	$5.97 - $9.58 $169,977 - $272,761	-28,472 Reduced 1.06%	2,664,131 $20.6 Million
Q1 2018 May 14, 2018	SELL	$4.21 - $7.0 $2.72 Million - $4.52 Million	-645,343 Reduced 19.33%	2,692,603 $17.5 Million
Q3 2017 Nov 13, 2017	BUY	$3.9 - $6.78 $13 Million - $22.6 Million	3,337,946	3,337,946 $14 Million

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $15.9M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Senvest Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Senvest Management, LLC with notifications on news.